Long-term persistence and boostability of immune responses following different rabies pre-exposure prophylaxis priming schedules of a purified chick embryo cell rabies vaccine administered alone or concomitantly with a Japanese encephalitis vaccine., PMID:40424340
Long-Term Oral Administration of Hyperimmune Egg-Based IgY-Rich Formulations Induces Mucosal Immune Response and Systemic Increases of Cytokines Involved in Th2- and Th17-Type Immune Responses in C57BL/6 Mice., PMID:39201385
Molecular signatures of Haemonchus contortus infection in sheep: A comparative serum proteomic study on susceptible and resistant sheep breeds., PMID:39116550
Phase II Trial of HER-Vaxx, a B-cell Peptide-Based Vaccine, in HER2-Overexpressing Advanced Gastric Cancer Patients Under Platinum-Based Chemotherapy (HERIZON)., PMID:39028916
Single cell analyses reveal the PD-1 blockade response-related immune features in hepatocellular carcinoma., PMID:38948071
A mutation in Themis contributes to anaphylaxis severity following oral peanut challenge in CC027 mice., PMID:38670234
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease., PMID:38563762
A measles virus-based vaccine induces robust chikungunya virus-specific CD4+ T-cell responses in a phase II clinical trial., PMID:37726181
Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents., PMID:37310433
Removal of chromatin by salt-tolerant endonucleases for production of recombinant measles virus., PMID:36974026
Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine: a randomised, placebo-controlled, first-in-human trial., PMID:36934733
Development of the B cell cancer vaccine HER-vaxx for the treatment of her-2 expressing cancers., PMID:36578947
Biodistribution and toxicology evaluation of a recombinant measles Schwarz-based Lassa vaccine in cynomolgus macaques., PMID:36480160
Combined Vaccination with B Cell Peptides Targeting Her-2/neu and Immune Checkpoints as Emerging Treatment Option in Cancer., PMID:36428769
Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis., PMID:35544087
Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1-2 randomised controlled trial., PMID:35461522
Seroprevalence of IgG antibodies against SARS-CoV-2 - a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020., PMID:35241216
A Combined Echocardiography Approach for the Diagnosis of Cancer Therapy-Related Cardiac Dysfunction in Women With Early-Stage Breast Cancer., PMID:35138325
Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study., PMID:35045362
Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ranging trial., PMID:35042081
Vaccination against Her-2/neu, with focus on peptide-based vaccines., PMID:35026721
Impact of Maternal Pertussis Antibodies on the Infants' Cellular Immune Responses., PMID:34849638
Emerging targets for anticancer vaccination: PD-1., PMID:34649221
Antibody effector analysis of prime versus prime-boost immunizations with a recombinant measles-vectored chikungunya virus vaccine., PMID:34582377
SARS-CoV-2 seroprevalence survey among health care providers in a Belgian public multiple-site hospital., PMID:34372955
Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27-45 years of age compared to women 16-26 years of age: An open-label phase 3 study., PMID:33676783
Hospital-wide SARS-CoV-2 antibody screening of staff in a university psychiatric centre in Belgium., PMID:33468277
Statin Exposure and Risk of Heart Failure After Anthracycline- or Trastuzumab-Based Chemotherapy for Early Breast Cancer: A Propensity Score‒Matched Cohort Study., PMID:33401953
Long-term immunogenicity, effectiveness, and safety of nine-valent human papillomavirus vaccine in girls and boys 9 to 15 years of age: Interim analysis after 8 years of follow-up., PMID:32659510
Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections., PMID:32373111
Safety and immunogenicity of fully liquid and lyophilized formulations of an investigational trivalent group B streptococcus vaccine in healthy non-pregnant women: Results from a randomized comparative phase II trial., PMID:32169390
Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth., PMID:31948817
Analysis of Humoral Immune Responses in Chikungunya Virus (CHIKV)-Infected Patients and Individuals Vaccinated With a Candidate CHIKV Vaccine., PMID:31828322
Genetic Variants Predisposing Most Strongly to Type 1 Diabetes Diagnosed Under Age 7 Years Lie Near Candidate Genes That Function in the Immune System and in Pancreatic β-Cells., PMID:31558544
[Clostridium Difficile: Monoclonal Antibody Therapy and Vaccines]., PMID:31212328
Immunogenicity and Efficacy of a Measles Virus-Vectored Chikungunya Vaccine in Nonhuman Primates., PMID:31053842
Monitoring stress-induced autophagic engulfment and degradation of the 26S proteasome in mammalian cells., PMID:30910028
Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial., PMID:30409443
Chikungunya Virus Vaccines: Viral Vector-Based Approaches., PMID:27920181
In vivo immunotoxicity of perfluorooctane sulfonate in BALB/c mice: Identification of T-cell receptor and calcium-mediated signaling pathway disruption through gene expression profiling of the spleen., PMID:26300304
Genome-wide association study of recalcitrant atopic dermatitis in Korean children., PMID:25935106
Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial., PMID:25739878
Themis2 is not required for B cell development, activation, and antibody responses., PMID:24907343
Development of type 1 diabetes mellitus in nonobese diabetic mice follows changes in thymocyte and peripheral T lymphocyte transcriptional activity., PMID:21765850
Mice that lack matrix metalloproteinase-9 display delayed wound healing associated with delayed reepithelization and disordered collagen fibrillogenesis., PMID:19379668
The molecular basis of allorecognition in ascidians., PMID:18937348
Intrauterine therapy with cytomegalovirus hyperimmunoglobulin for a fetus congenitally infected with cytomegalovirus., PMID:17845336
Permanent phenotypic correction of hemophilia B in immunocompetent mice by prenatal gene therapy., PMID:15231566
Ultrasound-guided percutaneous delivery of adenoviral vectors encoding the beta-galactosidase and human factor IX genes to early gestation fetal sheep in utero., PMID:12659676
In utero gene transfer of human factor IX to fetal mice can induce postnatal tolerance of the exogenous clotting factor., PMID:12393743
For research use only. Not for human or drug use.
